1. Home
  2. DIN vs SAGE Comparison

DIN vs SAGE Comparison

Compare DIN & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DIN
  • SAGE
  • Stock Information
  • Founded
  • DIN 1958
  • SAGE 2010
  • Country
  • DIN United States
  • SAGE United States
  • Employees
  • DIN N/A
  • SAGE N/A
  • Industry
  • DIN Restaurants
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • DIN Consumer Discretionary
  • SAGE Health Care
  • Exchange
  • DIN Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • DIN 494.3M
  • SAGE 462.2M
  • IPO Year
  • DIN 1991
  • SAGE 2014
  • Fundamental
  • Price
  • DIN $30.39
  • SAGE $5.61
  • Analyst Decision
  • DIN Buy
  • SAGE Hold
  • Analyst Count
  • DIN 8
  • SAGE 19
  • Target Price
  • DIN $40.83
  • SAGE $11.53
  • AVG Volume (30 Days)
  • DIN 502.6K
  • SAGE 1.1M
  • Earning Date
  • DIN 11-06-2024
  • SAGE 02-12-2025
  • Dividend Yield
  • DIN 6.71%
  • SAGE N/A
  • EPS Growth
  • DIN 25.34
  • SAGE N/A
  • EPS
  • DIN 6.02
  • SAGE N/A
  • Revenue
  • DIN $813,838,000.00
  • SAGE $106,399,000.00
  • Revenue This Year
  • DIN N/A
  • SAGE N/A
  • Revenue Next Year
  • DIN $0.65
  • SAGE $122.78
  • P/E Ratio
  • DIN $5.05
  • SAGE N/A
  • Revenue Growth
  • DIN N/A
  • SAGE 837.60
  • 52 Week Low
  • DIN $28.25
  • SAGE $4.62
  • 52 Week High
  • DIN $51.35
  • SAGE $28.26
  • Technical
  • Relative Strength Index (RSI)
  • DIN 40.31
  • SAGE 50.27
  • Support Level
  • DIN $29.47
  • SAGE $4.94
  • Resistance Level
  • DIN $32.05
  • SAGE $5.91
  • Average True Range (ATR)
  • DIN 1.38
  • SAGE 0.36
  • MACD
  • DIN -0.38
  • SAGE 0.02
  • Stochastic Oscillator
  • DIN 15.16
  • SAGE 69.07

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations, and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: